Skip to content
Application 761235
- Type
- BLA
- Sponsor
- GENENTECH INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FARICIMAB | VABYSMO | INJECTABLE; INTRAVITREAL | 120MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-096 | VABYSMO | Faricimab | Genentech, Inc. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 85678 | SUPPL | 2026-04-14 |
| 85670 | SUPPL | 2026-04-10 |
| 79109 | SUPPL | 2024-07-17 |
| 79054 | SUPPL | 2024-07-12 |
| 75979 | SUPPL | 2023-10-27 |
| 75962 | SUPPL | 2023-10-27 |
| 73327 | SUPPL | 2023-01-30 |
| 73315 | SUPPL | 2023-01-30 |
| 70274 | ORIG | 2022-02-28 |
| 70038 | ORIG | 2022-02-01 |
| 70002 | ORIG | 2022-01-31 |